• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?SNCA、MAPT 和 LRRK2 基因之间的相互作用是否有助于帕金森病的易感性?
Parkinsonism Relat Disord. 2011 Dec;17(10):730-6. doi: 10.1016/j.parkreldis.2011.07.001. Epub 2011 Aug 3.
2
Genetic susceptibility loci, environmental exposures, and Parkinson's disease: a case-control study of gene-environment interactions.遗传易感性位点、环境暴露与帕金森病:基因-环境相互作用的病例对照研究。
Parkinsonism Relat Disord. 2013 Jun;19(6):595-9. doi: 10.1016/j.parkreldis.2013.02.008. Epub 2013 Mar 16.
3
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.LRRK2 p.R1398H 对帕金森病风险的保护作用独立于 MAPT 和 SNCA 变异。
Neurobiol Aging. 2014 Jan;35(1):266.e5-14. doi: 10.1016/j.neurobiolaging.2013.07.013. Epub 2013 Aug 17.
4
Common variants in PARK loci and related genes and Parkinson's disease.常见的 PARK 基因座和相关基因变异与帕金森病。
Mov Disord. 2011 Feb 1;26(2):280-8. doi: 10.1002/mds.23376. Epub 2010 Dec 13.
5
Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.评估 LRRK2、MAPT、SNCA 和 TCEANC2 基因的风险因子变异在匈牙利散发性帕金森病患者中的作用。
Neurosci Lett. 2019 Jul 27;706:140-145. doi: 10.1016/j.neulet.2019.05.014. Epub 2019 May 11.
6
Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: a replication study in a Taiwanese cohort.SNCA 和 LRRK2 基因的遗传变异与散发性 PD 易感性相关:在台湾队列中的复制研究。
Parkinsonism Relat Disord. 2013 Feb;19(2):251-5. doi: 10.1016/j.parkreldis.2012.10.019. Epub 2012 Nov 20.
7
SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population.SNCA 和 MAPT 基因:意大利人群帕金森病中的独立和联合作用。
Parkinsonism Relat Disord. 2012 Mar;18(3):257-62. doi: 10.1016/j.parkreldis.2011.10.014. Epub 2011 Nov 21.
8
MAPT IVS1+124 C>G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals.在中国人群中,微管相关蛋白tau基因内含子1+124 C>G修饰了富含亮氨酸重复激酶2基因G2385R导致帕金森病的风险。
Neurobiol Aging. 2014 Jul;35(7):1780.e7-1780.e10. doi: 10.1016/j.neurobiolaging.2014.01.025. Epub 2014 Jan 25.
9
Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.MAPT 和 SNCA 基因在帕金森病中的独立和共同作用。
Ann Neurol. 2011 May;69(5):778-92. doi: 10.1002/ana.22321. Epub 2011 Mar 9.
10
Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.帕金森病中五个孟德尔基因及全基因组关联研究中顶级基因的重测序分析。
Mol Neurodegener. 2016 Apr 19;11:29. doi: 10.1186/s13024-016-0097-0.

引用本文的文献

1
α-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies.α-突触核蛋白与tau蛋白:相互作用、交叉播种以及将突触核蛋白病重新定义为复杂蛋白质病
Front Neurosci. 2025 Mar 27;19:1570553. doi: 10.3389/fnins.2025.1570553. eCollection 2025.
2
Alpha-Synuclein and Cognitive Decline in Parkinson Disease.帕金森病中的α-突触核蛋白与认知衰退
Life (Basel). 2021 Nov 16;11(11):1239. doi: 10.3390/life11111239.
3
LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson's Disease?富含亮氨酸重复激酶2与α-突触核蛋白:帕金森病中各自独立还是协同发挥作用的因素?
Front Neurosci. 2020 Jun 17;14:577. doi: 10.3389/fnins.2020.00577. eCollection 2020.
4
The unlikely partnership between LRRK2 and α-synuclein in Parkinson's disease.LRRK2 与 α-突触核蛋白在帕金森病中的不寻常伙伴关系。
Eur J Neurosci. 2019 Feb;49(3):339-363. doi: 10.1111/ejn.14182. Epub 2018 Oct 24.
5
Interaction between SNCA, LRRK2 and GAK increases susceptibility to Parkinson's disease in a Chinese population.在中国人群中,α-突触核蛋白(SNCA)、富亮氨酸重复激酶2(LRRK2)和GAK之间的相互作用增加了患帕金森病的易感性。
eNeurologicalSci. 2015 Aug 7;1(1):3-6. doi: 10.1016/j.ensci.2015.08.001. eCollection 2015 Mar.
6
Genetic Variants in SNCA and the Risk of Sporadic Parkinson's Disease and Clinical Outcomes: A Review.SNCA基因变异与散发性帕金森病风险及临床结局:一项综述
Parkinsons Dis. 2017;2017:4318416. doi: 10.1155/2017/4318416. Epub 2017 Jul 11.
7
Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson's Disease Assessed by the Unified Parkinson's Disease Rating Scale and the Hoehn-Yahr Stage.探索基因变异对帕金森病临床特征的影响,通过统一帕金森病评定量表和霍恩-亚尔分级进行评估。
PLoS One. 2016 Jun 14;11(6):e0155758. doi: 10.1371/journal.pone.0155758. eCollection 2016.
8
Phosphatases of α-synuclein, LRRK2, and tau: important players in the phosphorylation-dependent pathology of Parkinsonism.α-突触核蛋白、LRRK2 和 tau 的磷酸酶:帕金森病磷酸化依赖病理的重要参与者。
Front Genet. 2014 Nov 7;5:382. doi: 10.3389/fgene.2014.00382. eCollection 2014.
9
Identifying the Association Between Alzheimer's Disease and Parkinson's Disease Using Genome-Wide Association Studies and Protein-Protein Interaction Network.利用全基因组关联研究和蛋白质-蛋白质相互作用网络确定阿尔茨海默病与帕金森病之间的关联。
Mol Neurobiol. 2015 Dec;52(3):1629-1636. doi: 10.1007/s12035-014-8946-8. Epub 2014 Nov 5.
10
Alpha-synuclein and tau: teammates in neurodegeneration?α-突触核蛋白与tau蛋白:神经退行性变中的协同因子?
Mol Neurodegener. 2014 Oct 29;9:43. doi: 10.1186/1750-1326-9-43.

本文引用的文献

1
Common variants in PARK loci and related genes and Parkinson's disease.常见的 PARK 基因座和相关基因变异与帕金森病。
Mov Disord. 2011 Feb 1;26(2):280-8. doi: 10.1002/mds.23376. Epub 2010 Dec 13.
2
Tau protein: relevance to Parkinson's disease.tau 蛋白:与帕金森病的关系。
Int J Biochem Cell Biol. 2010 Nov;42(11):1775-8. doi: 10.1016/j.biocel.2010.07.016. Epub 2010 Aug 1.
3
Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline.β-淀粉样蛋白、tau 蛋白和 α-突触核蛋白之间的协同作用:神经病理学和认知能力下降的加速。
J Neurosci. 2010 May 26;30(21):7281-9. doi: 10.1523/JNEUROSCI.0490-10.2010.
4
Mechanisms in dominant parkinsonism: The toxic triangle of LRRK2, alpha-synuclein, and tau.优势型帕金森病的发病机制:LRRK2、α-突触核蛋白和tau 的毒性三角。
Bioessays. 2010 Mar;32(3):227-235. doi: 10.1002/bies.200900163.
5
Leucine-rich repeat kinase 2 induces alpha-synuclein expression via the extracellular signal-regulated kinase pathway.富含亮氨酸重复激酶 2 通过细胞外信号调节激酶通路诱导α-突触核蛋白表达。
Cell Signal. 2010 May;22(5):821-7. doi: 10.1016/j.cellsig.2010.01.006. Epub 2010 Jan 13.
6
Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease.全基因组关联研究证实,α-突触核蛋白基因(SNCA)和微管相关蛋白tau基因(MAPT)区域的单核苷酸多态性(SNPs)是帕金森病的常见风险因素。
Ann Hum Genet. 2010 Mar;74(2):97-109. doi: 10.1111/j.1469-1809.2009.00560.x. Epub 2010 Jan 8.
7
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease.全基因组关联研究确定了四个位点的常见变异为帕金森病的遗传风险因素。
Nat Genet. 2009 Dec;41(12):1303-7. doi: 10.1038/ng.485. Epub 2009 Nov 15.
8
Genome-wide association study reveals genetic risk underlying Parkinson's disease.全基因组关联研究揭示帕金森病的遗传风险。
Nat Genet. 2009 Dec;41(12):1308-12. doi: 10.1038/ng.487. Epub 2009 Nov 15.
9
Whole-genome conditional two-locus analysis identifies novel candidate genes for late-onset Parkinson's disease.全基因组条件双基因座分析确定了迟发性帕金森病的新候选基因。
Neurogenetics. 2009 Jul;10(3):173-81. doi: 10.1007/s10048-009-0170-8. Epub 2009 Jan 21.
10
Genomewide association study for susceptibility genes contributing to familial Parkinson disease.家族性帕金森病易感性基因的全基因组关联研究。
Hum Genet. 2009 Jan;124(6):593-605. doi: 10.1007/s00439-008-0582-9. Epub 2008 Nov 6.

SNCA、MAPT 和 LRRK2 基因之间的相互作用是否有助于帕金森病的易感性?

Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?

机构信息

Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55095, USA.

出版信息

Parkinsonism Relat Disord. 2011 Dec;17(10):730-6. doi: 10.1016/j.parkreldis.2011.07.001. Epub 2011 Aug 3.

DOI:10.1016/j.parkreldis.2011.07.001
PMID:21816655
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4723425/
Abstract

BACKGROUND

Polymorphisms in SNCA, MAPT and LRRK2 genes have recently been confirmed as risk factors for Parkinson's disease (PD), although with small individual attributable risk. Here we investigated the association of PD with interactions between variants of these genes.

METHODS

As part of a previous study of PD susceptibility genes 119 SNCA, MAPT, and LRRK2 haplotype tagging single nucleotide polymorphisms (SNPs) and two variable number tandem repeats (VNTRs) were genotyped in 1098 PD cases from the upper Midwest, USA and 1098 matched controls. Twenty-six of these SNPs were selected for SNP-SNP (or SNP-VNTR or VNTR-VNTR) interaction analysis (256 interaction pairs). Case-control analyses were performed to study association of pairwise SNP interactions with PD susceptibility.

RESULTS

Out of the 256 interaction pairs investigated, 10 had uncorrected p-values <0.05. These represented six SNCA-LRRK2 pairs, three SNCA-MAPT pairs, and one MAPT-LRRK2 pair. However, none of these pairwise interactions were significant after correction for multiple testing. Secondary analyses in strata defined by type of control (sibling or unrelated), sex, or age at onset of the case also did not reveal any significant interactions after accounting for multiple testing.

CONCLUSIONS

This study provides no statistically significant evidence of gene-gene interaction effects for the three confirmed genetic susceptibility loci for PD. However, this does not exclude the possibility that other genomic loci or environmental risk factors interact with these genes.

摘要

背景

SNCA、MAPT 和 LRRK2 基因中的多态性最近被证实是帕金森病(PD)的风险因素,尽管个体归因风险较小。在这里,我们研究了这些基因变异之间的相互作用与 PD 的关联。

方法

作为 PD 易感性基因研究的一部分,我们对来自美国中西部的 1098 例 PD 病例和 1098 例匹配对照进行了 119 个 SNCA、MAPT 和 LRRK2 单倍型标签单核苷酸多态性(SNP)和两个可变数串联重复(VNTR)的基因分型。选择了其中的 26 个 SNP 进行 SNP-SNP(或 SNP-VNTR 或 VNTR-VNTR)相互作用分析(256 个相互作用对)。进行病例对照分析以研究成对 SNP 相互作用与 PD 易感性的关联。

结果

在所研究的 256 个相互作用对中,有 10 对的未校正 p 值<0.05。这代表了六个 SNCA-LRRK2 对、三个 SNCA-MAPT 对和一个 MAPT-LRRK2 对。然而,在进行多次检验校正后,这些成对相互作用均无统计学意义。在根据对照类型(同胞或无关)、性别或病例发病年龄定义的亚组中进行的二次分析,在考虑到多次检验后也没有发现任何显著的相互作用。

结论

这项研究没有提供三个已确认的 PD 遗传易感性基因座的基因-基因相互作用效应的统计学显著证据。然而,这并不排除其他基因组区域或环境风险因素与这些基因相互作用的可能性。